Home » Newsletters » BioWorld MedTech

BioWorld MedTech

March 7, 2012

View Archived Issues

European Congress of Radiology: Tomosynthesis systems ready to follow on Hologic success

VIENNA No matter how you slice it, Hologic (Bedford, Massachusetts) has created a market for tomosynthesis. Read More

Washington roundup: FDA wants routine audits of Synthes USA after inspection

K2M adds to spine portfolio with FDA clearance of Santorini

NewCo on the Block: Ivantis enrolls first patient in Hydrus Microstent study

Financings roundup: NLT Spine increases funding to a total of $14.5 million

Patent watch: Vermillion gets allowance for platelet biomarkers

Agreements/contracts: Abbott, Merck make FISH diagnostic test

Deals roundup: Excelitas Technologies completes acquisition of Carsan Engineering

Court report: Precision files patent suit against Cellectis

HIT roundup: Fujifilm wins EHR certification for Synapse RIS version 6.1

People in the News

Product Briefs

MDD's Oncology Extra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 14, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
Australian researchers discover new compound to treat long COVID
BioWorld
Researchers have developed a new compound that can prevent long COVID symptoms in mice that could lead to a future drug for the debilitating condition in humans....